The Hildeguard Group is a funding community led by experts, powered by passionate investors and scientists, dedicated to the development of breakthrough prescription botanical medicines that will benefit billions. Our world today is experiencing epidemic levels of complex illnesses of the mind and immune system. Existing therapeutics and treatment paradigms fail to recognise or treat the body as an interconnected system out of balance. In doing so, as a society, we fail to address the suffering of the hundreds of millions of people worldwide affected by auto-immune and Neuro conditions. Emerging research indicates that complex botanical medicines show additional efficacy compared to their isolated synthetic comparators and the potential to offer massive therapeutic potential in treating disease. They are also radically cheaper and quicker to develop than classic drugs. However, there is a systemic underfunding of early stage botanical drug development, driven by ignorance, stigma, and a lack of sector expertise. We are building our exclusive list of founding members. People who want to transform medicine through our unique impact investment community. Join Us.